These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36513039)

  • 1. The Effectiveness of Metacognitive Therapy Compared to Behavioral Activation for Severely Depressed Outpatients: A Single-Center Randomized Trial.
    Schaich A; Outzen J; Assmann N; Gebauer C; Jauch-Chara K; Alvarez-Fischer D; Hüppe M; Wells A; Schweiger U; Klein JP; Fassbinder E
    Psychother Psychosom; 2023; 92(1):38-48. PubMed ID: 36513039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial.
    Callesen P; Reeves D; Heal C; Wells A
    Sci Rep; 2020 May; 10(1):7878. PubMed ID: 32398710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRO
    Schaich A; Heikaus L; Assmann N; Köhne S; Jauch-Chara K; Hüppe M; Wells A; Schweiger U; Klein JP; Fassbinder E
    Front Psychiatry; 2018; 9():584. PubMed ID: 30510523
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of metacognitive training for depression as add-on intervention for patients with depression in acute intensive psychiatric inpatient care: A randomized controlled trial.
    Hauschildt M; Arlt S; Moritz S; Yassari AH; Jelinek L
    Clin Psychol Psychother; 2022 Sep; 29(5):1542-1555. PubMed ID: 35274407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of Metacognitive Training for Depression (D-MCT): A randomized controlled trial.
    Jelinek L; Faissner M; Moritz S; Kriston L
    Br J Clin Psychol; 2019 Sep; 58(3):245-259. PubMed ID: 30556583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and moderators of metacognitive training for depression in older adults (MCT-Silver): A randomized controlled trial.
    Schneider BC; Veckenstedt R; Karamatskos E; Ahlf-Schumacher J; Gehlenborg J; Schultz J; Moritz S; Jelinek L
    J Affect Disord; 2024 Jan; 345():320-334. PubMed ID: 37865342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized controlled trial.
    Driessen E; Van HL; Schoevers RA; Cuijpers P; van Aalst G; Don FJ; Hendriksen M; Kool S; Molenaar PJ; Peen J; Dekker JJ
    BMC Psychiatry; 2007 Oct; 7():58. PubMed ID: 17963493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effectiveness of two models of brief psychotherapy for depression: A three-year follow-up randomized clinical trial.
    Dos Santos ÉN; Molina ML; Mondin T; Cardoso TA; Silva R; Souza L; Jansen K
    Psychiatry Res; 2020 Apr; 286():112804. PubMed ID: 32001003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Sleep Disturbance Symptoms on Treatment Outcome in Blended Cognitive Behavioral Therapy for Depression (E-COMPARED Study): Secondary Analysis.
    Jensen ES; Ladegaard N; Mellentin AI; Ebert DD; Titzler I; Araya R; Cerga Pashoja A; Hazo JB; Holtzmann J; Cieslak R; Smoktunowicz E; Baños R; Herrero R; García-Palacios A; Botella C; Berger T; Krieger T; Holmberg TT; Topooco N; Andersson G; van Straten A; Kemmeren L; Kleiboer A; Riper H; Mathiasen K
    J Med Internet Res; 2022 Mar; 24(3):e30231. PubMed ID: 35311687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Metacognitive Therapy in Patients With Depression and Comorbid Anxiety Symptoms: A Case Series From India.
    Sharma V; Sagar R; Kaloiya G; Mehta M
    Cureus; 2022 Apr; 14(4):e24229. PubMed ID: 35602823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial.
    Schramm E; Kriston L; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Bausch P; Fangmeier T; Meister R; Berger M; Hautzinger M; Härter M
    JAMA Psychiatry; 2017 Mar; 74(3):233-242. PubMed ID: 28146251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol.
    Ferrari GR; Becker ES; Smit F; Rinck M; Spijker J
    BMC Psychiatry; 2016 Nov; 16(1):370. PubMed ID: 27809880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression.
    Vittengl JR; Clark LA; Jarrett RB
    J Affect Disord; 2009 Jan; 112(1-3):135-43. PubMed ID: 18539337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: PATHWAY-A Single-Blind, Parallel, Randomized, Controlled Trial of Group Metacognitive Therapy.
    Wells A; Reeves D; Capobianco L; Heal C; Davies L; Heagerty A; Doherty P; Fisher P
    Circulation; 2021 Jul; 144(1):23-33. PubMed ID: 34148379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study.
    Winter L; Schweiger U; Kahl KG
    BMC Psychiatry; 2020 Nov; 20(1):566. PubMed ID: 33243217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the first French psychoeducational program on unipolar depression: study protocol for a randomized controlled trial.
    Ducasse D; Courtet P; Sénèque M; Genty C; Picot MC; Schwan R; Olié E
    BMC Psychiatry; 2015 Nov; 15():294. PubMed ID: 26578205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmenting neurocognitive remediation therapy to Preventive Cognitive Therapy for partially remitted depressed patients: protocol of a pragmatic multicentre randomised controlled trial.
    Bockting C; Legemaat AM; van der Stappen JGJ; Geurtsen GJ; Semkovska M; Burger H; Bergfeld IO; Lous N; Denys DAJP; Brouwer M
    BMJ Open; 2022 Jun; 12(6):e063407. PubMed ID: 35738653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open trial of group metacognitive therapy for depression in Norway.
    Dammen T; Papageorgiou C; Wells A
    Nord J Psychiatry; 2015 Feb; 69(2):126-31. PubMed ID: 25124119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.